GlassScriptPhysician profile
Tuvi Mendel
NPI 1033189535
$26,349.17
in general payments reported to CMS, 2019-2025
16 companies · $2,108 in 2025
The $2,108 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,973 · 2020: $1,141 · 2021: $5,389 · 2022: $9,681 · 2023: $2,038 · 2024: $3,020 · 2025: $2,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,685 · Travel and Lodging: $1,922 · Education: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,684.76 |
| Travel and Lodging | $1,922.20 |
| Education | $559.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,255.12 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Mako |
| Wardlow Enterprises | $6,791.73 | 2019-2022 | |
| Arthrex, INC. | $6,219.28 | 2019-2022 | |
| Nuvasive, INC. | $735.03 | 2022-2023 | Xlif, Alif, Brigade |
| Wright Medical Technology, INC. | $677.77 | 2019 | |
| Prism Medical | $502.96 | 2025 | |
| Ferring Pharmaceuticals INC. | $396.50 | 2021-2025 | Euflexxa |
| Ethicon US, LLC | $222.41 | 2023-2025 | Dermabond Prineo, Stratafix, Dermabond |
| Convatec INC. | $188.24 | 2023-2024 | |
| Microport Orthopedics INC | $141.29 | 2019 | |
| Pacira Therapeutics, INC. | $92.22 | 2021 | |
| Globus Medical, INC. | $36.81 | 2025 | Xlif |
| Biocomposites INC | $27.32 | 2025 | Stimulan |
| Orthofix Medical, INC. | $26.02 | 2024 | Physio-Stim |
| Medtronic, INC. | $21.69 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuvi Mendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.